Lataa...
Risk factors for disease progression in HER2-positive breast cancer patients based on the location of metastases
INTRODUCTION: Trastuzumab therapy significantly improves progression-free and overall survival in HER2-positive [HER2(+)] breast cancer (BC) patients. However, in most patients with HER2(+) metastatic BC, the disease progress occurred. The aim of this study was to evaluate the clinicopathological ri...
Tallennettuna:
| Julkaisussa: | Prz Menopauzalny |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Termedia Publishing House
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4612553/ https://ncbi.nlm.nih.gov/pubmed/26528105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/pm.2015.54341 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|